The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lessened its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 8.5% in the second quarter, Holdings Channel reports. The fund owned 3,212,393 shares of the medical device company’s stock after selling 300,149 shares during the quarter. Victory Capital Management Inc.’s holdings in Cooper Companies were worth $280,442,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Cooper Companies by 303.0% in the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after purchasing an additional 17,367,502 shares during the last quarter. Capital World Investors grew its position in shares of Cooper Companies by 301.7% during the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after acquiring an additional 4,246,519 shares during the last quarter. Janus Henderson Group PLC increased its holdings in shares of Cooper Companies by 279.8% in the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after acquiring an additional 2,532,186 shares during the period. Bessemer Group Inc. boosted its stake in Cooper Companies by 305.2% during the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after purchasing an additional 1,507,049 shares during the period. Finally, Swedbank AB bought a new position in Cooper Companies in the 1st quarter worth about $139,246,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on COO shares. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and lifted their price target for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Robert W. Baird increased their price target on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Piper Sandler lifted their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Finally, Wells Fargo & Company increased their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $113.61.

Cooper Companies Stock Up 0.9 %

Cooper Companies stock opened at $106.50 on Friday. The company has a market capitalization of $21.21 billion, a P/E ratio of 62.65, a P/E/G ratio of 2.56 and a beta of 0.98. The firm’s fifty day simple moving average is $92.92 and its 200-day simple moving average is $94.55. The company has a current ratio of 1.99, a quick ratio of 1.14 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $107.46.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.05. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.84 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.66 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.